Filed for bankruptcy in Dec 2023
MKUL - Molekule Group, Inc.
NASDAQ
->
Industrials
->
Pollution & Treatment Controls
Palm Beach Gardens,
United States
Type: Equity
MKUL price evolution
MKUL
| (in millions $) | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 | 29 Oct 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2.2 | $1 | ||
| Inventory | $29.4 | $29.7 | $2 | $1.3 |
| Total current assets | $39.3 | $40.5 | $24.8 | $27.4 |
| Long term investments | ||||
| Property, plant & equipment | $19.6 | $21.5 | $3.7 | $2.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $125.4 | $128.5 | $29.2 | $29.6 |
| Current liabilities | ||||
| Accounts payable | $6.6 | $10.8 | $3.2 | $0.9 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $17.3 | $20.4 | $4.6 | $2.7 |
| Long term debt | $34.1 | $33.9 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $84.7 | $64.7 | $9.5 | $5.9 |
| Shareholders' equity | ||||
| Retained earnings | -$42.8 | -$17.9 | -$7.9 | -$2.8 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $0.04 | $0.18 | $0.1 | |
| Inventory | $2.02 | $0.65 | ||
| Total current assets | $24.78 | $21.58 | $2.74 | |
| Long term investments | ||||
| Property, plant & equipment | $3.73 | $2.12 | $0.45 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $29.16 | $23.72 | $3.19 | |
| Current liabilities | ||||
| Accounts payable | $3.22 | $0.93 | $0.33 | $0.14 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $4.56 | $1.51 | $0.67 | $0.23 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $9.46 | $2.01 | $0.67 | $0.23 |
| Shareholders' equity | ||||
| Retained earnings | -$7.92 | -$1.75 | -$8.22 | -$4.9 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13.24 | $8.35 | $0.09 | $0.06 |
| Cost of revenue | ||||
| Gross Profit | $4.48 | $3.68 | $0.05 | $0.03 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $16.19 | $13.92 | $4.97 | $5.08 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.09 | -$0.07 | -$0.21 | |
| Interest expense | -$13.49 | $0.48 | -$0.22 | $11.49 |
| Net income | ||||
| Net income | -$24.97 | -$9.93 | -$5.07 | $6.65 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.23 | $0.62 | ||
| Cost of revenue | ||||
| Gross Profit | $0.11 | $0.28 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $17.32 | $8.52 | $3.32 | $0.15 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.5 | -$0.32 | ||
| Interest expense | $10.62 | |||
| Net income | ||||
| Net income | -$6.17 | -$7.92 | -$3.32 | -$0.15 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $1.79 | $2.55 | -$0.51 | -$0.16 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $9.37 | -$0.17 | $13.58 | $13.58 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$16.17 | -$13.66 | $2.43 | $6.19 |
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$0.51 | -$1.75 | -$0.45 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $13.58 | $26.84 | $5.86 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2.43 | $17.29 | $2.34 | -$0.1 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 34.00M |
| Revenue | $21.74M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$33.32M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.98 |
|---|---|
| ROA | -42.62% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.27 |
| Quick ratio | 0.57 |